ZNF573

ZNF573 is a transcription factor that controls cell- and tissue-specific gene expression programs governing developmental timing and proliferation (PMID:26671628, PMID:40973794). In the neuroendocrine control of puberty, delivery of ZNF573 to the rat hypothalamus delays pubertal onset by impairing the transition of a transcriptional network from a repressive epigenetic configuration toward activation, defining ZNF573 as a transcriptional repressor in this setting (PMID:26671628). In prostate cancer cells, ZNF573 instead promotes expression of the E3 ubiquitin ligase RNF19B, which drives ubiquitination of PIK3CA, and ZNF573 overexpression suppresses proliferation and invasion both in vitro and in xenografts (PMID:40973794). Beyond these two contexts, the direct DNA-binding targets, structural basis of transcriptional regulation, and mechanism by which ZNF573 selects activating versus repressive outputs have not been characterized in the available corpus.

1. 2015 Medium

   Established that ZNF573 functions as a transcriptional repressor in vivo, linking it to the neuroendocrine timing of puberty rather than leaving it an uncharacterized zinc-finger protein.

   Evidence Stereotaxic targeted delivery of a ZNF573 construct to the rat hypothalamus with pubertal timing as functional readout

   PMID:26671628

   Open questions at the time

   • No direct DNA-binding targets or response elements identified for ZNF573
   • Mechanism distinguishing ZNF573's contribution from co-studied factors not resolved
   • No structural or domain-level basis for repressive activity
2. 2025 Medium

   Placed ZNF573 in a defined regulatory axis by showing it promotes RNF19B expression to drive PIK3CA ubiquitination and restrain prostate cancer cell proliferation and invasion.

   Evidence ZNF573 overexpression in prostate cancer cells (in vitro and xenograft) with RNF19B expression analysis and PIK3CA ubiquitination assay

   PMID:40973794

   Open questions at the time

   • Single lab, single study without mutagenesis or reconstitution
   • Whether ZNF573 binds the RNF19B promoter directly is not established
   • Reconciliation of repressor (hypothalamus) versus activator (RNF19B) roles is unresolved

• How ZNF573 selects its genomic targets and switches between transcriptional activation and repression across tissues remains unknown.
• No ChIP-seq or direct binding-site identification
• No structural model of the DNA-binding domain
• Cofactors mediating activating versus repressive outputs unidentified